These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 7474246
41. The influence of the sparteine/debrisoquine genetic polymorphism on the disposition of dexfenfluramine. Gross AS, Phillips AC, Rieutord A, Shenfield GM. Br J Clin Pharmacol; 1996 Apr; 41(4):311-7. PubMed ID: 8730977 [Abstract] [Full Text] [Related]
42. Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men. Dickstein K, Aarsland T. Am J Ophthalmol; 1996 Apr; 121(4):367-71. PubMed ID: 8604729 [Abstract] [Full Text] [Related]
43. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel. Uusitalo H, Niño J, Tahvanainen K, Turjanmaa V, Ropo A, Tuominen J, Kähönen M. Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651 [Abstract] [Full Text] [Related]
44. Short-term Efficacy and Safety of Topical β-Blockers (Timolol Maleate Ophthalmic Solution, 0.5%) in Acute Migraine: A Randomized Crossover Trial. Kurian A, Reghunadhan I, Thilak P, Soman I, Nair U. JAMA Ophthalmol; 2020 Nov 01; 138(11):1160-1166. PubMed ID: 33001159 [Abstract] [Full Text] [Related]
45. Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan. Desmeules JA, Oestreicher MK, Piguet V, Allaz AF, Dayer P. J Pharmacol Exp Ther; 1999 Feb 01; 288(2):607-12. PubMed ID: 9918565 [Abstract] [Full Text] [Related]
46. Systemic absorption of ocular timolol in poor and extensive metabolizers of debrisoquine. Huupponen R, Kaila T, Lahdes K, Salminen L, Iisalo E. J Ocul Pharmacol; 1991 Feb 01; 7(2):183-7. PubMed ID: 1919275 [Abstract] [Full Text] [Related]
53. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Kirchheiner J, Heesch C, Bauer S, Meisel C, Seringer A, Goldammer M, Tzvetkov M, Meineke I, Roots I, Brockmöller J. Clin Pharmacol Ther; 2004 Oct 01; 76(4):302-12. PubMed ID: 15470329 [Abstract] [Full Text] [Related]
56. Quinidine reduces clearance of (+)-propranolol more than (-)-propranolol through marked reduction in 4-hydroxylation. Zhou HH, Anthony LB, Roden DM, Wood AJ. Clin Pharmacol Ther; 1990 Jun 01; 47(6):686-93. PubMed ID: 2357863 [Abstract] [Full Text] [Related]
57. Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6. Young D, Midha KK, Fossler MJ, Hawes EM, Hubbard JW, McKay G, Korchinski ED. Eur J Clin Pharmacol; 1993 Jun 01; 44(5):433-8. PubMed ID: 8359179 [Abstract] [Full Text] [Related]
58. Effects of beta-blockers association with pilocarpine on rabbit intraocular pressure and heart rate. Drago F, Emmi I, Marino V. Pharmacol Res; 1997 Apr 01; 35(4):299-302. PubMed ID: 9264045 [Abstract] [Full Text] [Related]
59. Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients. Nieminen T, Uusitalo H, Turjanmaa V, Bjärnhall G, Hedenström H, Mäenpää J, Ropo A, Heikkilä P, Kähönen M. Eur J Clin Pharmacol; 2005 Jul 01; 61(5-6):369-74. PubMed ID: 15912390 [Abstract] [Full Text] [Related]